Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
St. Louis Center for Clinical Research
408
mi
from
St. Louis, MO
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
St. Louis Center for Clinical Research
408
mi
from
St. Louis, MO
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
Arthritis Center of Nebraska
215
mi
from
Lincoln, NE
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Arthritis Center of Nebraska
215
mi
from
Lincoln, NE
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
Pacific Arthritis Center Medical Group
261
mi
from
Omaha, NE
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Pacific Arthritis Center Medical Group
261
mi
from
Omaha, NE
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
Rheumatoid Arthritis Investigational Network
261
mi
from
Omaha, NE
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Rheumatoid Arthritis Investigational Network
261
mi
from
Omaha, NE
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
Montefiore Medical Center
1293
mi
from
Bronx, NY
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Montefiore Medical Center
1293
mi
from
Bronx, NY
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
North Shore University Hospital
1301
mi
from
Great Neck, NY
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
North Shore University Hospital
1301
mi
from
Great Neck, NY
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
DJL Clinical Research
958
mi
from
Charlotte, NC
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
DJL Clinical Research
958
mi
from
Charlotte, NC
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
PMG Research of Wilmington
1135
mi
from
Wilmington, NC
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
PMG Research of Wilmington
1135
mi
from
Wilmington, NC
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
Altoona Center for Clinical Research
1053
mi
from
Duncansville, PA
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Altoona Center for Clinical Research
1053
mi
from
Duncansville, PA
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
Low Country Rheumatology
1063
mi
from
Charleston, SC
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Low Country Rheumatology
1063
mi
from
Charleston, SC
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
The Arthritis Clinic
518
mi
from
Jackson, TN
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
The Arthritis Clinic
518
mi
from
Jackson, TN
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
Texas Physicians Medical Research Group
348
mi
from
Arlington, TX
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Texas Physicians Medical Research Group
348
mi
from
Arlington, TX
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
Metroplex Clinical Research Center
341
mi
from
Dallas, TX
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Metroplex Clinical Research Center
341
mi
from
Dallas, TX
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
Pioneer Research Solutions, Inc.
570
mi
from
Houston, TX
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Pioneer Research Solutions, Inc.
570
mi
from
Houston, TX
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
Arthritis Northwest Rheumatology
1202
mi
from
Spokane, WA
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Arthritis Northwest Rheumatology
1202
mi
from
Spokane, WA
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
Rheumatic Disease Center
638
mi
from
Glendale, WI
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Rheumatic Disease Center
638
mi
from
Glendale, WI
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
Gundersen Lutheran Medical Center
545
mi
from
Onalaska, WI
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Gundersen Lutheran Medical Center
545
mi
from
Onalaska, WI
Click here to add this to my saved trials
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated:  1/5/2016
Brest Regional Clinical Hospital
4470
mi
from
Brest,
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel in Subjects With Rheumatoid Arthritis and Inadequate Response to Treatment With Methotrexate
Status: Enrolling
Updated: 1/5/2016
Brest Regional Clinical Hospital
4470
mi
from
Brest,
Click here to add this to my saved trials
Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty With Attune Knee System
Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty
Status: Enrolling
Updated:  1/5/2016
OrthoCarolina Research Institute
959
mi
from
Charlotte, NC
Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty With Attune Knee System
Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty
Status: Enrolling
Updated: 1/5/2016
OrthoCarolina Research Institute
959
mi
from
Charlotte, NC
Click here to add this to my saved trials
Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty With Attune Knee System
Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty
Status: Enrolling
Updated:  1/5/2016
The University of Tennessee
777
mi
from
Knoxville, TN
Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty With Attune Knee System
Kinematic Analysis: Posterior Stabilized, Fixed Bearing Total Knee Arthroplasty
Status: Enrolling
Updated: 1/5/2016
The University of Tennessee
777
mi
from
Knoxville, TN
Click here to add this to my saved trials
Antifolate Effectiveness in Arthritis
Mechanisms of Antifolate Efficacy in Arthritis
Status: Enrolling
Updated:  1/5/2016
University of Alabama at Birmingham
676
mi
from
Birmingham, AL
Antifolate Effectiveness in Arthritis
Mechanisms of Antifolate Efficacy in Arthritis
Status: Enrolling
Updated: 1/5/2016
University of Alabama at Birmingham
676
mi
from
Birmingham, AL
Click here to add this to my saved trials
Improving Vocational Outcomes in Arthritis
Improving Vocational Outcomes in Arthritis
Status: Enrolling
Updated:  1/5/2016
University of Alabama at Birmingham
676
mi
from
Birmingham, AL
Improving Vocational Outcomes in Arthritis
Improving Vocational Outcomes in Arthritis
Status: Enrolling
Updated: 1/5/2016
University of Alabama at Birmingham
676
mi
from
Birmingham, AL
Click here to add this to my saved trials
Registry for African Americans With Early Rheumatoid Arthritis
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated:  1/5/2016
University of Alabama at Birmingham
676
mi
from
Birmingham, AL
Registry for African Americans With Early Rheumatoid Arthritis
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated: 1/5/2016
University of Alabama at Birmingham
676
mi
from
Birmingham, AL
Click here to add this to my saved trials
Registry for African Americans With Early Rheumatoid Arthritis
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated:  1/5/2016
Emory University
801
mi
from
Atlanta, GA
Registry for African Americans With Early Rheumatoid Arthritis
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated: 1/5/2016
Emory University
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
Registry for African Americans With Early Rheumatoid Arthritis
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated:  1/5/2016
Washington University, St. Louis
413
mi
from
St. Louis, MO
Registry for African Americans With Early Rheumatoid Arthritis
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated: 1/5/2016
Washington University, St. Louis
413
mi
from
St. Louis, MO
Click here to add this to my saved trials
Registry for African Americans With Early Rheumatoid Arthritis
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated:  1/5/2016
University of North Carolina at Chapel Hill
1038
mi
from
Chapel Hill, NC
Registry for African Americans With Early Rheumatoid Arthritis
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated: 1/5/2016
University of North Carolina at Chapel Hill
1038
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Registry for African Americans With Early Rheumatoid Arthritis
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated:  1/5/2016
Medical University of South Carolina
1063
mi
from
Charleston, SC
Registry for African Americans With Early Rheumatoid Arthritis
Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (CLEAR)
Status: Enrolling
Updated: 1/5/2016
Medical University of South Carolina
1063
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Arizona Arthritis and Rheumatology Research
854
mi
from
Glendale, AZ
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Arizona Arthritis and Rheumatology Research
854
mi
from
Glendale, AZ
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Sun Valley Arthritis Center, Ltd
858
mi
from
Peoria, AZ
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Sun Valley Arthritis Center, Ltd
858
mi
from
Peoria, AZ
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Valley Arthritis Care, LLC
852
mi
from
Phoenix, AZ
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Valley Arthritis Care, LLC
852
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
University of Boards Regent
833
mi
from
Tucson, AZ
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
University of Boards Regent
833
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Valley Endocrine, Fresno
1205
mi
from
Fresno, CA
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Valley Endocrine, Fresno
1205
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Desert Medical Advances
1075
mi
from
Palm Desert, CA
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Desert Medical Advances
1075
mi
from
Palm Desert, CA
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Pacific Arthritis Center
1184
mi
from
Santa Maria, CA
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Pacific Arthritis Center
1184
mi
from
Santa Maria, CA
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Inlande Rheumatology Clinical Trials
1135
mi
from
Upland, CA
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Inlande Rheumatology Clinical Trials
1135
mi
from
Upland, CA
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Boulder Medical Center
431
mi
from
Boulder, CO
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Boulder Medical Center
431
mi
from
Boulder, CO
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Clinical Research Center of CT/NY
1317
mi
from
Danbury, CT
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Clinical Research Center of CT/NY
1317
mi
from
Danbury, CT
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
New England Research Associates, Llc
1329
mi
from
Trumbull, CT
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
New England Research Associates, Llc
1329
mi
from
Trumbull, CT
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Delaware Arthritis
1229
mi
from
Lewes, DE
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Delaware Arthritis
1229
mi
from
Lewes, DE
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Orthopedic Research Institute
1292
mi
from
Boynton Beach, FL
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Orthopedic Research Institute
1292
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Jeffrey Alper MD
1232
mi
from
Naples, FL
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Jeffrey Alper MD
1232
mi
from
Naples, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Sun Coast Clinical Research, Inc
1091
mi
from
New Port Richey, FL
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Sun Coast Clinical Research, Inc
1091
mi
from
New Port Richey, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Rheumatology Associates of Central Florida
1143
mi
from
Orlando, FL
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Rheumatology Associates of Central Florida
1143
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Integral Rheumatology & Immunology Specialists
1302
mi
from
Plantation, FL
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Integral Rheumatology & Immunology Specialists
1302
mi
from
Plantation, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
McIlwain Medical Group
1110
mi
from
Tampa, FL
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
McIlwain Medical Group
1110
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Indiana University Health
643
mi
from
Indianapolis, IN
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Indiana University Health
643
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Diagnostic Rheumatology and Research PC
643
mi
from
Indianapolis, IN
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Diagnostic Rheumatology and Research PC
643
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
Goldpoint Clinical Research
643
mi
from
Indianapolis, IN
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
Goldpoint Clinical Research
643
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
West Michigan Rheumatology
739
mi
from
Grand Rapids, MI
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
West Michigan Rheumatology
739
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated:  1/6/2016
University of Missouri
308
mi
from
Columbia, MO
A Study in Moderate to Severe Rheumatoid Arthritis
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
Status: Enrolling
Updated: 1/6/2016
University of Missouri
308
mi
from
Columbia, MO
Click here to add this to my saved trials